Helping In-patients to Quit Smoking by Understanding Their Risk Perception, Behavior, and Attitudes Related to Smoking

July 12, 2018 updated by: Dr. LI William Ho Cheung, The University of Hong Kong
This study aims at understanding the needs and concerns of Chinese current smoking patients, including their risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation. Specifically, how smokers overcome withdrawal symptoms and cigarette cravings, as a result of banning on smoking in hospitals, will be explored. In addition, whether smokers will stop, resume or continue smoking after hospitalization will be investigated.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

As about 400,000 hospitalizations are attributable to smoking annually in Hong Kong, it is an excellent "teachable moment" for healthcare professionals to help patients quit smoking. To our knowledge, this is the first study to investigate the needs and concerns of Chinese current smoking patients, including their risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation. The findings of this study have important implications for research and clinical practice.

Understanding how hospitalized smokers perceive the risks of smoking, and their behaviour, attitudes, experiences related to smoking, as well as their view on hospital smoking cessation service are essential prerequisites for the design of an effective and appropriate smoking cessation intervention that can help patients achieve a greater level of smoking abstinence and a lower level of relapse. Moreover, the results of this study can guide the development of protocols and interventions that will demystify the misconceptions about smoking among hospitalized smokers, increase their perception of the risks of continued smoking and benefits of quitting. Additionally, it is crucial to motivate more healthcare professionals to assess health behaviors of hospitalized smokers and to implement evidence-based interventions to help them quit smoking. Most importantly, healthcare professionals should be offered relevant training so as to enhance their self-efficacy and confidence in promoting smoking cessation to patients.

The study consists of 2 phases. During phase 1, a purposive sample of 30 current adult smokers who admit to either medical or surgical units of one of the largest cute hospitals in Hong Kong will be invited to have a 60-minute semi-structured interview. The risk perceptions, and the behaviour, attitudes, and experiences related to smoking and smoking cessation amongst Chinese current smoking patients will be explored. Concerning phase 2, a convenience sample of 382 adult patients who are current smokers or ex-smokers in the three out-patient clinics will be invited to response to the questionnaires. Based on the findings of Phase 1 study, a survey study will be conducted to further explore the behaviour, attitudes, and experiences related to smoking and smoking cessation amongst those patient who smoked before their admission to hospitals.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
412

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Hong Kong, China
        • The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Phase 1 Qualitative study:

Chinese patients admitting to either medical or surgical units of one of the largest acute hospital in Hong Kong for physical discomfort.

Phase 2 Survey study:

Chinese patients attending one of the three general outpatient clinics at different regions in Hong Kong for medical follow-up.

Description

Inclusion Criteria:

  1. aged 18 years or above
  2. able to speak Cantonese Phase 1:(3) current smokers, either occasional or daily(4) hospitalized for at least 48 hours Phase 2:(3) current smokers who have resumed smoking or ex-smokers who have quitted smoking after hospitalization(4) admitted to hospitals, either medical or surgical units during the past 3 months.

Exclusion Criteria:

  1. unstable medical conditions, as advised by the doctor in charge
  2. poor cognitive state or active psychotic symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The behavior, attitudes, and experiences related to smoking and smoking cessation among Chinese current smoking patients
Time Frame: 3 months
  1. smoking patients' risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation
  2. how they overcome withdrawal symptoms and cigarette cravings, as well as their view on hospital smoking cessation service
3 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The behavior, attitudes, and experiences related to smoking and smoking cessation among those patients who smoked before their admission to hospitals
Time Frame: 10 months
whether they (1) experience withdrawal symptoms or cigarette cravings and depressive symptoms during and after hospitalization (2)receive medical advice for quitting during hospitalization (3) have stopped, resumed or continued smoking after hospitalization (4) have intention to quit (5) have an increase in the risk perception toward smoking.
10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 1, 2016

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 29, 2017

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 29, 2017

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 4, 2016

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 10, 2016

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 15, 2016

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 13, 2018

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 12, 2018

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • In-patient

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings